NCT00929799View on ClinicalTrials.gov

Growth Hormone and Glucose Metabolism

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Growth Hormone Deficiency
Interventions
DRUG

recombinant human Growth Hormone (Genotropin® )

Once daily by subcutaneous injection using a Genotropin pen in the abdomen at 22:00 h. Maximal GH dose of 0.003 mg/kg/day.

Trial Locations (1)

12200

Charite Campus Benjamin Franklin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT00929799 - Growth Hormone and Glucose Metabolism | Biotech Hunter | Biotech Hunter